- Recommendation ID
- IPG530/1
- Question
NICE encourages further research into transcranial direct current stimulation (tDCS) for depression, which should document how patients were selected and any other treatments they were having. It should describe the precise method and regime used for administering tDCS. Outcome measures should include the duration of effect. NICE may update the guidance on publication of further evidence.
- Any explanatory notes
(if applicable) The evidence on transcranial direct current stimulation (tDCS) for depression raises no major safety concerns. There is some evidence of efficacy but there are uncertainties about the specific mode of administration, the number of treatments needed and the duration of effect. Therefore, this procedure should only be used with special arrangements for clinical governance, consent and audit or research.
Source guidance details
- Comes from guidance
- Transcranial direct current stimulation (tDCS) for depression
- Number
- IPG530
- Date issued
- August 2015
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |